William E. Martin III - 21 Aug 2023 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Signature
/s/ Kurt Oreshack, by power of attorney for William E. Martin, III
Issuer symbol
MRVI
Transactions as of
21 Aug 2023
Net transactions value
$0
Form type
4
Filing time
22 Aug 2023, 16:22:36 UTC
Previous filing
19 Oct 2022
Next filing
17 Oct 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRVI Performance Stock Units Award $0 +300,000 $0.000000 300,000 21 Aug 2023 Class A Common Stock 300,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units ("PSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan (the "Omnibus Incentive Plan"). Each PSU represents the contingent right to receive one share of Class A Common Stock of the Issuer. The PSUs will vest on August 21, 2026, if and to the extent the volume-weighted average price of a share of the Class A Common Stock of the Issuer equals or exceeds certain thresholds for the 60 consecutive trading days immediately preceding August 21, 2026, provided that in the event of a Change in Control (as defined in the Omnibus Incentive Plan) prior to August 21, 2026, the PSUs will convert to time-based restricted stock units that will fully vest on August 21, 2026, subject to the Reporting Person's continued employment with the Issuer through such date.